Behavioral
Intercessory Prayer
Intercessory Prayer is a behavioral intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (25.0%)
N/A3 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Medical Effects of Proximal (In-person) Intercessory (PIP) and Virtual Intercessory Prayer (VIP) on Pain and Anxiety
NCT07565142
completednot_applicable
Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial
NCT02716467
completednot_applicable
Effects of Remote Intercessory Prayer
NCT01053780
completedphase_3
Study of the Therapeutic Effects of Intercessory Prayer (STEP)
NCT00179491
Clinical Trials (4)
Showing 4 of 4 trials
NCT07565142Not Applicable
Medical Effects of Proximal (In-person) Intercessory (PIP) and Virtual Intercessory Prayer (VIP) on Pain and Anxiety
NCT02716467Not Applicable
Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial
NCT01053780Not Applicable
Effects of Remote Intercessory Prayer
NCT00179491Phase 3
Study of the Therapeutic Effects of Intercessory Prayer (STEP)
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4